Lack of reactivation of cytomegalovirus (CMV) retinitis after stopping CMV maintenance therapy in AIDS patients with sustained elevations in CD4 T cells in response to highly active antiretroviral therapy

Journal of Infectious Diseases

Volumn 177, Issue 5, 1998, Pages 1182-1187

  Christopher Macdonald, J ^b   Torriani, Francesca J ^b   Morse, Lawrence S ^b   Karavellas, Marietta P ^b   Brian Reed, J ^b   Freeman, William R ^a  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CIDOFOVIR; DIDANOSINE; FOSCARNET; GANCICLOVIR; INDINAVIR; LAMIVUDINE; NEVIRAPINE; RITONAVIR; SAQUINAVIR; STAVUDINE; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ANTIGEN DETECTION; ANTIVIRAL ACTIVITY; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; DRUG WITHDRAWAL; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; PRIORITY JOURNAL; RETINITIS; VIRUS INHIBITION; VIRUS REACTIVATION; VIRUS REPLICATION;

EID: 17344370672     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/515281     Document Type: Article

References (16)

1. Stein D, Drusano G, Steigbigel R, et al. Two year follow-up of patients treated with indinavir 800 mg q8h [abstract]. In: 4th Conference on Retroviruses and Opportunistic Infections: program and abstracts (Washington, DC). Alexandria, VA: Infectious Diseases Society of America, 1997:100.
2. 3 [abstract LB7]. In: 4th Conference on Retroviruses and Opportunistic Infections: program and abstracts (Washington, DC). Alexandria, VA: Infectious Diseases Society of America, 1997:50.
3. Cameron B, Heath-Chiozzi M, Kravcik S, et al. Prolongation of life and prevention of AIDS in advanced HIV immunodeficiency with ritonavir [abstract]. In: 3rd Conference on Retroviruses and Opportunistic Infections: program and abstracts (Washington, DC). Alexandria, VA: Infectious Diseases Society of America, 1996:162.
4. + T-cell repertoire that are not immediately restored by antiviral or immune-based therapies. Nature Med 1997;3:533-40.
5. Lederman M, Connici E, Landay A, et al. Partial immune reconstitution after 12 weeks of HAART (AZT, 3TC, ritonavir). Preliminary results of ACTG 315 [abstract]. In: 4th Conference on Retroviruses and Opportunistic Infections: program and abstracts (Washington, DC). Alexandria, VA: Infectious Diseases Society of America, 1997:208.
6. + T cell homeostasis and function in advanced HIV disease. Science 1997;277:112-6.
7. Baril L, Jouan M, Caumes E, Mengual X, Bricaire F, Katlama C. The impact of highly active antiretroviral therapy on the incidence of CMV disease in AIDS patients [abstract]. In: Program and abstracts of the 37th Interscience Conference on Antimicrobial Agents and Chemotherapy (Toronto). Washington, DC: American Society for Microbiology, 1997:248.
8. Michelet C, Arvieux C, Aubert V, Andre P, Riou A, Cartier F. Viral ocular involvement after initiation of antiprotease inhibitor therapy [abstract]. In: 4th Conference on Retroviruses and Opportunistic Infections: program and abstracts (Washington, DC). Alexandria, VA: Infectious Diseases Society of America, 1997:122.
9. Gilquin J, Piketty C, Thomas V, Gonzales-Canali G, Kazatchkine MD. Acute CMV infection in AIDS patients receiving combination therapy including protease inhibitors [abstract]. In: 4th Conference on Retroviruses and Opportunistic Infections: program and abstracts (Washington, DC). Alexandria, VA: Infectious Diseases Society of America, 1997:129.
10. Jacobson MA, Zegans M, Pavan PR, et al. Cytomegalovirus retinitis after initiation of highly active antiretroviral therapy. Lancet 1997;349:1443-5.
11. Studies of Ocular complications of AIDS Research Group. Parenteral cidofovir for cytomegalovirus retinitis in patients with AIDS: the HPMPC peripheral cytomegalovirus retinitis trial. A randomized, controlled trial. Ann Intern Med 1997;126:264-74.
12. Holland GN, Buhles WC Jr, Mastre B, Kaplan HJ. A controlled retrospective study of ganciclovir treatment for cytomegalovirus retinopathy. Use of a standardized system for the assessment of disease outcome. Arch Ophthalmol 1989;107:1759-66.
13. Gross JG, Bozzette SA, Mathews WC, et al. Longitudinal study of cytomegalovirus retinitis in acquired immune deficiency syndrome. Ophthalmology 1990;97:681-6.
14. Flores-Aguilar M, Munguia D, Besen G, Gangan P, Arevalo JF, Freeman WR. Clinical versus fundus photographic evaluation of the status of cytomegalovirus retinitis in AIDS patients. Retina 1996;16:363-72.
15. Whitcup SM, Fortin E, Nussenblatt RB, Polis MA, Muccioli C, Belfort R Jr. Therapeutic effect of combination antiretroviral therapy on cytomegalovirus retinitis [letter]. JAMA 1997;277:1519-20.
16. Kirsch LS, Arevalo JF, Chavez de la Paz E, Munguia D, De Clerq E, Freeman WR. Intravitreal cidofovir (HPMPC) treatment of cytomegalovirus retinitis in patients with acquired immune deficiency syndrome. Ophthalmology 1995;102:533-42.